#BEGIN_DRUGCARD DB04033

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C16H20N2O5

# Chemical_IUPAC_Name:
(2S)-1-[(2S)-2-{[(benzyloxy)carbonyl]amino}propanoyl]pyrrolidine-2-carboxylic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Z-Ala Prolinal

# HET_ID:
ZAH

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C16H20N2O5/c1-11(14(19)18-9-5-8-13(18)15(20)21)17-16(22)23-10-12-6-3-2-4-7-12/h2-4,6-7,11,13H,5,8-10H2,1H3,(H,17,22)(H,20,21)/t11-,13-/m0/s1

# InChI_Key:
InChIKey=RSSOZTMMMIWOJB-AAEUAGOBSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4033

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
320.3404

# Molecular_Weight_Mono:
320.13722176

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
2BKL

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.97

# Predicted_LogS:
-2.5

# Predicted_Water_Solubility:
8.97e-01 g/l

# Primary_Accession_No:
DB04033

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
5388928

# PubChem_Substance_ID:
46508805

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT03282

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@@](C)(NC(=O)OCC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:52 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AF127082

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
pep

# Drug_Target_1_Gene_Sequence:
>2070 bp
ATGTCCTACCCGGCGACCCGGGCGGAGCAGGTTGTCGACACGTTGCACGGCGTCCAGGTA
GCGGACCCGTATCGCTGGCTCGAGGACGAGAAGGCCCCCGAGGTCCAGACGTGGATGACG
GCGCAGAACGCGCACGCCCGCGAAGCGCTGGCGAAGTTCCCCGGCCGTGAGGCCCTGGCC
GCGCGCTTCAAGGAGCTGTTCTACACCGACTCCGTCTCCACCCCGTCGCGCCGCAACGGG
CGCTTCTTCTACGTCCGCACCCACAAGGACAAGGAGAAGGCCATCCTCTACTGGCGCCAG
GGGGAGAGCGGGCAGGAGAAGGTGCTGTTGGATCCGAACGGCTGGAGCAAGGACGGCACC
GTGTCCCTGGGGACGTGGGCCGTGTCCTGGGACGGCAAGAAGGTGGCCTTCGCCCAGAAG
CCCAACGCCGCGGATGAGGCGGTGCTGCACGTCATCGACGTGGACTCTGGCGAGTGGTCC
AAGGTGGACGTCATCGAGGGCGGCAAGTACGCCACGCCCAAGTGGACGCCCGACAGCAAG
GGCTTCTATTACGAGTGGCTGCCCACGGACCCGTCCATCAAGGTGGACGAGCGCCCCGGC
TACACCACCATCCGCTACCACACGCTGGGCACGGAGCCGTCGAAGGACACCGTGGTGCAC
GAGCGCACCGGCGACCCGACGACGTTCCTCCAGAGCGACCTGAGCCGCGACGGCAAGTAC
CTGTTCGTCTACATCCTCCGCGGCTGGAGCGAGAACGACGTCTACTGGAAGCGGCCGGGT
GAGAAGGACTTCCGCCTGCTGGTGAAGGGCGTGGGCGCCAAGTACGAGGTGCACGCCTGG
AAGGACCGCTTCTACGTCCTCACCGACGAGGGCGCCCCGCGCCAGCGCGTCTTCGAGGTG
GATCCGGCGAAGCCGGCCCGCGCGTCGTGGAAGGAGATTGTCCCCGAGGACTCGTCCGCG
TCCCTGCTGTCCGTCAGCATCGTCGGCGGGCACCTGTCGCTGGAGTACCTCAAGGACGCG
ACGTCCGAGGTGCGCGTGGCCACGCTGAAGGGCAAGCCGGTGCGCACGGTGCAGCTGCCG
GGCGTGGGCGCGGCGTCCAACCTGATGGGGCTGGAGGACCTGGATGACGCCTACTACGTC
TTCACGTCCTTCACCACGCCCCGTCAAATCTACAAGACGTCCGTCAGCACCGGGAAGTCT
GAGCTCTGGGCCAAGGTGGACGTGCCCATGAACCCGGAGCAGTACCAGGTCGAGCAGGTC
TTCTACGCGTCCAAGGACGGGACGAAGGTGCCCATGTTCGTGGTGCACCGCAAGGACCTG
AAGCGTGACGGCAACGCGCCCACGCTGCTCTACGGCTACGGCGGCTTCAACGTGAACATG
GAGGCCAACTTCCGCTCGAGCATCCTGCCCTGGCTGGACGCGGGCGGCGTGTACGCGGTG
GCCAACCTGCGCGGCGGCGGCGAGTACGGCAAGGCCTGGCACGACGCCGGCCGCCTGGAC
AAGAAGCAGAACGTCTTCGACGACTTCCACGCGGCGGCCGAGTACTTGGTCCAGCAGAAG
TACACGCAGCCCAAGCGGCTGGCCATCTACGGCGGCAGCAACGGCGGCCTGCTGGTGGGC
GCGGCCATGACGCAGCGGCCGGAGCTGTACGGCGCGGTGGTGTGCGCGGTGCCCCTGCTG
GACATGGTGCGCTACCACCTCTTCGGCAGCGGCCGGACCTGGATTCCGGAGTACGGCACG
GCGGAGAAGCCCGAGGACTTCAAGACGCTGCACGCCTACTCGCCCTACCACCACGTGCGG
CCGGACGTGCGCTACCCCGCGCTGCTGATGATGGCGGCGGACCACGACGACCGGGTGGAC
CCCATGCACGCCCGCAAGTTCGTGGCGGCGGTGCAGAACTCGCCCGGAAACCCGGCGACG
GCCCTGCTGCGCATCGAGGCCAACGCGGGCCACGGTGGCGCGGATCAGGTGGCCAAGGCC
ATTGAGTCCAGCGTGGACCTGTATTCGTTCCTGTTCCAAGTCCTGGATGTCCAGGGGGCA
CAGGGTGGGGTGGCGGCGCAGGGCCGCTGA

# Drug_Target_1_General_Function:
Involved in prolyl oligopeptidase activity

# Drug_Target_1_General_References:
Not Available

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
5450

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
76848

# Drug_Target_1_Name:
Prolyl endopeptidase Pep

# Drug_Target_1_Number_of_Residues:
689

# Drug_Target_1_PDB_ID:
2BKL

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00326	Peptidase_S9
PF02897	Peptidase_S9_N

# Drug_Target_1_Protein_Sequence:
>Prolyl endopeptidase Pep
MSYPATRAEQVVDTLHGVQVADPYRWLEDEKAPEVQTWMTAQNAHAREALAKFPGREALA
ARFKELFYTDSVSTPSRRNGRFFYVRTHKDKEKAILYWRQGESGQEKVLLDPNGWSKDGT
VSLGTWAVSWDGKKVAFAQKPNAADEAVLHVIDVDSGEWSKVDVIEGGKYATPKWTPDSK
GFYYEWLPTDPSIKVDERPGYTTIRYHTLGTEPSKDTVVHERTGDPTTFLQSDLSRDGKY
LFVYILRGWSENDVYWKRPGEKDFRLLVKGVGAKYEVHAWKDRFYVLTDEGAPRQRVFEV
DPAKPARASWKEIVPEDSSASLLSVSIVGGHLSLEYLKDATSEVRVATLKGKPVRTVQLP
GVGAASNLMGLEDLDDAYYVFTSFTTPRQIYKTSVSTGKSELWAKVDVPMNPEQYQVEQV
FYASKDGTKVPMFVVHRKDLKRDGNAPTLLYGYGGFNVNMEANFRSSILPWLDAGGVYAV
ANLRGGGEYGKAWHDAGRLDKKQNVFDDFHAAAEYLVQQKYTQPKRLAIYGGSNGGLLVG
AAMTQRPELYGAVVCAVPLLDMVRYHLFGSGRTWIPEYGTAEKPEDFKTLHAYSPYHHVR
PDVRYPALLMMAADHDDRVDPMHARKFVAAVQNSPGNPATALLRIEANAGHGGADQVAKA
IESSVDLYSFLFQVLDVQGAQGGVAAQGR

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
Q9X5N2

# Drug_Target_1_SwissProt_Name:
Q9X5N2_MYXXA

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
7.04

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04033
